ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Sexual Health and Reproductive Services

Liverpool City Council · awardUpdate, contractUpdate

Tender information last checkedLast checked 25 Sept 2026, 14:11.

Opportunity overview

The modification will continue previously approved service enhancements and support the expansion of key sexual health interventions for the remainder of the contract term. This includes widening access to HIV Pre-Exposure Prophylaxis (PrEP), implementing new Doxycycline Post-Exposure Prophylaxis (Doxy-PEP) interventions in line with national clinical guidance, and integrating Tuberculosis (TB) testing alongside existing STI and blood-borne virus screening services to improve outcomes for high-risk populations. The contract is also being extended by the full three-year option period. The service has been operational for over four years and continues to meet or exceed all key performance indicators, critical performance measures, and social value requirements. The extension option was provided for in the original procurement and hence there is no change to the lifetime value of the contract as a result of exercising this option.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Classification

  • CPV85140000 — Miscellaneous health services

Lots

  • The purpose and reasons for the modification are detailed below: Expanding HIV Pre-exposure prophylaxis (PrEP) - HIV PrEP is a vital tool for preventing HIV transmission. The contract currently delivers HIV PrEP but the Council intends to expand access to this to populations currently not accessing the service, including black and minority ethnic groups and women, with new injectable techniques likely to be more acceptable and accessible to these groups Doxycycline post-exposure prophylaxis (Doxy-PEP) - The UK has released its first national clinical guidelines for doxycycline post-exposure prophylaxis (Doxy-PEP) to prevent syphilis and chlamydia. New Doxy-PEP drug interventions are available and the Council is seeking to implement this guidance using new interventions. Integration of Tuberculosis (TB) testing - The Council is seeking to integrate testing of viral Hepatitis B and C and Tuberculosis (TB) into the service because these conditions can be effectively co-targeted with significant overlap with respect to specific cohorts at high risk. There is a high co-infection rate for TB and HIV. Testing at the same time allows for faster diagnosis, better treatment planning and helps prevent serious illness and spread. Whilst there is an existing TB prevention and control service which is delivered by the same provider (LUHFT) it is not commissioned by LCC and it does not offer latent TB screening. Adding TB testing to the existing contract will enable more effective and efficient targeting of population groups at increased risk of TB. The contracted provider is already targeting these at risk groups for STI and BBV screening.Value not stated

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
DN517038
Main Procurement Category
services

Legal basis

Id
32014L0024
Scheme
CELEX

Classification

Scheme
CPV
Id
85140000
Description
Miscellaneous health services

Lots and requirements

Entry 1
Id
1
Description
The purpose and reasons for the modification are detailed below: Expanding HIV Pre-exposure prophylaxis (PrEP) - HIV PrEP is a vital tool for preventing HIV transmission. The contract currently delivers HIV PrEP but the Council intends to expand access to this to populations currently not accessing the service, including black and minority ethnic groups and women, with new injectable techniques likely to be more acceptable and accessible to these groups Doxycycline post-exposure prophylaxis (Doxy-PEP) - The UK has released its first national clinical guidelines for doxycycline post-exposure prophylaxis (Doxy-PEP) to prevent syphilis and chlamydia. New Doxy-PEP drug interventions are available and the Council is seeking to implement this guidance using new interventions. Integration of Tuberculosis (TB) testing - The Council is seeking to integrate testing of viral Hepatitis B and C and Tuberculosis (TB) into the service because these conditions can be effectively co-targeted with significant overlap with respect to specific cohorts at high risk. There is a high co-infection rate for TB and HIV. Testing at the same time allows for faster diagnosis, better treatment planning and helps prevent serious illness and spread. Whilst there is an existing TB prevention and control service which is delivered by the same provider (LUHFT) it is not commissioned by LCC and it does not offer latent TB screening. Adding TB testing to the existing contract will enable more effective and efficient targeting of population groups at increased risk of TB. The contracted provider is already targeting these at risk groups for STI and BBV screening.

Contract period

Duration In Days
2,880

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UKD72

Buyer, suppliers and contacts

Organisation 1
Name
Liverpool City Council
Id
GB-FTS-145191

Identifier

Legal Name
Liverpool City Council
No Identifier Rationale
notOnAnyRegister

Address

Street Address
Cunard Building
Locality
Liverpool
Region
UKD72
Postal Code
L31DS
Country Name
United Kingdom

Contact

Name
Emma Hardman

Roles

buyer

Details

Organisation 2
Name
Liverpool University Hospitals NHS Foundation Trust
Id
GB-NHS-REM

Identifier

Legal Name
Liverpool University Hospitals NHS Foundation Trust
Id
REM
Scheme
GB-NHS

Address

Street Address
University Hospital Aintree, Broadgreen Hospital
Locality
Liverpool
Region
UKD72
Postal Code
L143LB
Country Name
United Kingdom

Contact

Roles

supplier

Details

Scale
large
Organisation 3
Name
Liverpool City Council
Id
GB-FTS-4530

Identifier

Legal Name
Liverpool City Council

Address

Locality
Liverpool
Country Name
United Kingdom

Roles

reviewBody

Award information

Award 1
Id
090979-2026-DN517038-1
Status
active

Related lots

1

Suppliers

Supplier 1
Id
GB-NHS-REM
Name
Liverpool University Hospitals NHS Foundation Trust

Contracts and changes

Entry 1
Id
090979-2026-DN517038-1
Award ID
090979-2026-DN517038-1
Status
active
Date Signed
20 Aug 2026, 00:00

Items

Item 1
Id
1
Related Lot
1

Classification

Scheme
CPV
Id
85100000
Description
Health services

Delivery locations

Entry 1
Region
UKD72

Value

Amount
52,376,880
Currency
GBP

Period

Duration In Days
2,880

Amendments

Entry 1
Id
1
Description
The modification will continue previously approved service enhancements and support the expansion of key sexual health interventions for the remainder of the contract term. This includes widening access to HIV Pre-Exposure Prophylaxis (PrEP), implementing new Doxycycline Post-Exposure Prophylaxis (Doxy-PEP) interventions in line with national clinical guidance, and integrating Tuberculosis (TB) testing alongside existing STI and blood-borne virus screening services to improve outcomes for high-risk populations. The contract is also being extended by the full three-year option period. The service has been operational for over four years and continues to meet or exceed all key performance indicators, critical performance measures, and social value requirements. The extension option was provided for in the original procurement and hence there is no change to the lifetime value of the contract as a result of exercising this option.
Rationale
Need for additional works, services or supplies by the original contractor/concessionaire: This is a permitted modification under regulation 13(3)(d) of the Provider Selection Regime Regulations 2023, a contract may be modified where the change is required in response to external factors beyond the control of both the relevant authority and the provider, The modification does not alter the overall nature of the current contract. The contract was varied to support the delivery of enhanced sexual health and HIV prevention initiatives, including expanded access to HIV PrEP, the introduction of Doxy-PEP for the prevention of syphilis and chlamydia, and increased TB testing and treatment pathways for at-risk populations. Additional funding was provided to create capacity for integrated TB advice, testing and referral services within the contract. As Liverpool's designated sexual health provider, Axess implemented these enhanced interventions, which continue to support the objectives of Liverpool's Sexual & Reproductive Health and HIV Strategy by reducing inequalities, improving access to preventative services and strengthening health outcomes. The continuation of the variation throughout the proposed three-year extension period will ensure these interventions remain embedded within service delivery and allow the provider to continue meeting current and emerging population health needs.

Recorded locations

  • Buyer location · Liverpool · UKD72 · L31DS · United Kingdom
  • Delivery location · UKD72

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. 090979-2026awardUpdate, contractUpdate ·